AQP4 and myeloid sarcoma: This prevented us from comparing lipid levels between AQP4 antibody-positive and AQP4 antibody-negative NMOSD, and we were unable to validate our findings on the basis of prior studies since this is the first study to compare the CSF lipidome between NMOSD and MS.